Imagion Biosystems Halts Trading Pending Capital Raise
Key points
- Trading in Imagion Biosystems Limited (ASX: IBX) securities halted
- Halt requested to manage continuous disclosure obligations
- Expected announcement before June 25, 2026
Full summary
Imagion Biosystems Limited (ASX: IBX) has requested a trading halt on the Australian Securities Exchange (ASX) to manage its continuous disclosure obligations. The halt is necessary as the company expects to release a material announcement related to a capital raise. The trading halt will remain in effect until the earlier of the commencement of normal trading on June 25, 2026, or the release of the announcement. The company does not foresee any issues with the halt being granted.
Outlook
The company expects to make the announcement before the commencement of normal trading on Thursday, June 25, 2026.
Summary generated by a large language model. Please interpret with care.